Use of Ceramide C16:0 and Ceramide Synthase 6 in the Treatment and Diagnosis of Multiple Sclerosis
The C16:0-ceramide biomarkers described here, allow both the diagnosis and monitoring of autoimmune disease multiple sclerosis. Moreover the ceramide synthase 6 (CerS6) outlined in this invention serves as target for the treatment of MS.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0
Contact
Dr. Otmar Schöller
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Decoding development: mRNA’s role in embryo formation
A new study at Hebrew University reveals insights into mRNA regulation during embryonic development. The study combines single-cell RNA-Seq and metabolic labeling in zebrafish embryos, distinguishing between newly-transcribed and pre-existing…
Study sheds light on cancer cell ‘tug-of-war’
How cancer cells tug against each other determines whether they can migrate elsewhere in the body. Understanding how cancerous cells spread from a primary tumor is important for any number…
Latest generation of self-dissolving stents
Magnesium implants support coronary arteries and keep them open. Constricted coronary arteries harbor dangers: Because the heart is not supplied with blood properly, this can lead to pain, cardiac arrhythmia,…
